Advertisement

Medical Microbiology and Immunology

, Volume 171, Issue 2, pp 113–122 | Cite as

Disorders of neutrophil function in children with recurrent pyogenic infections

  • F. Patrone
  • F. Dallegri
  • E. Bonvini
  • F. Minervini
  • C. Sacchetti
Article

Abstract

Ten patients with neutrophil dysfunctions and recurrent pyogenic infections, mainly of the skin, middle ear, and respiratory tract, are described. The most frequently affected functions were chemotaxis and bacterial killing. Pharmacologic restoration of functional defects was tried in all cases. Levamisole was given in two cases and ascorbic acid in the other eight cases. During a follow up of at least 18 months, seven patients showed a complete restoration of neutrophil function and a long-lasting clinical remission. One of the two patients with Chronic Granulomatous Disease has been free from infections for 1 year, despite persistent neutrophil dysfunction, while the other did not display consistent clinical improvement. Another patient, who was given ascorbic acid for a short period only due to non compliance, showed neither laboratory nor clinical improvement.

Keywords

Ascorbic Acid Respiratory Tract Clinical Improvement Clinical Remission Levamisole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson R, Theron A (1979) Effects of ascorbate on leucocytes. Part III. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate. S Afr Med J 56:429–433PubMedGoogle Scholar
  2. Anderson R, Dittrich OC (1979) Effects of ascorbate on leucocytes. Part IV. Increased netrophil function and clinical improvement after oral ascorbate in 2 patients with Chronic Granulomatous Disease. S Afr Med J 56:476–479PubMedGoogle Scholar
  3. Boxer LA, Vanderbilt B, Bonsib S, Jersild R, Yang HH, and Baehner RL (1979) Enhancement of chemotactic response and microtubule assembly in human leukocytes by ascorbic acid. J Cell Physiol 100:119–124CrossRefPubMedGoogle Scholar
  4. Clark RA (1978) Disorders of granulocyte chemotaxis. In: Leukocyte chemotaxis: methods, physiology and clinical implications (eds. Gallin JI and Quie PG) pp. 329–356. Raven Press, New YorkGoogle Scholar
  5. Dallegri F, Lanzi G, Patrone F (1980) Effects of ascorbic acid on neutrophil locomotion. Int Archs Allergy appl Immun 61:40–45Google Scholar
  6. Eschenbach C, Hahm W, Becker D (1979) Influence of levamisole on the capacity of neutrophil granulocytes for ingestion and reduction of nitroblue tetrazolium. Blut 39:383–391CrossRefPubMedGoogle Scholar
  7. Gabig TG (1980) Leukocyte abnormalities. Med Clin North Amer 64:647–666Google Scholar
  8. Gallin JI, Clark RA, Frank MM (1975) Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternative pathways. Clin Immunol Immunopathol 3:334–336CrossRefPubMedGoogle Scholar
  9. Gallin JI, Wright DG, Malech HL, Davis JM, Klempner MS, Kirkpatrick CH (1980) Disorders of phagocyte chemotaxis. Ann Int Med 92:520–538PubMedGoogle Scholar
  10. Hill HR, Quie PG (1974) Raised serum lgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet I:183–187CrossRefGoogle Scholar
  11. Holmes B, Page AR, Good RA (1967) Studies on the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest 46:1422–1432PubMedGoogle Scholar
  12. Miller ME (1977) Disorders of neutrophil function. Am J Hemat 3:257–261PubMedGoogle Scholar
  13. Nonoyama S, Kojo H, Mine Y, Nishida M, Goto S, Kuwahara S (1979) Inhibitory effect of Pseudomonas aeruginosa on the phagocytic and killing activities of rabbit polymorphonuclear leukocytes: purification and characterization of an inhibitor of polymorphonuclear leukocyte function. Infect Immun 24:394–399PubMedGoogle Scholar
  14. Patrone F, Dallegri F, Bonvini E, Sacchetti C (1980) In vitro effects of synthetic chemotactic peptides on neutrophil function. Int Archs Allergy appl Immun 62:316–323Google Scholar
  15. Quie PG, Cates KL (1978) Clinical manifestations of disorders of neutrophil chemotaxis. In: Leukocyte chemotaxis: methods, physiology and clinical implications (eds. Gallin JI and Quie PG) pp. 307–324, Raven Press, New YorkGoogle Scholar
  16. Quie PG, Mills EL, McPhail LC, Johnston RB (1978) Phagocytic defects. Springer Semin Immunopathol 1:323–337CrossRefGoogle Scholar
  17. Rabson AR, Anderson R, Glover A (1978) Defective neutrophil motility and recurrent infections. In vitro and in vivo effects of levamisole. Clin Exp Immunol 33:142–149PubMedGoogle Scholar
  18. Rebora A, Dallegri F, Patrone F (1980) Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid. Br J Dermatol 102:49–56PubMedGoogle Scholar
  19. Schmeling DJ, Peterson PK, Hammerschmidt DE, Kim H, Verhoef J, Wilkinson BJ, Quie PG (1979) Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun 26:57–65PubMedGoogle Scholar
  20. Shurin SB, Socransky SS, Sweeney E, Stossel TP (1979) A neutrophil disorder induced by capnocytophaga, a dental micro-organism. N Engl J Med 301:849–854PubMedGoogle Scholar
  21. Skeel RT, Yankee RA, Spivak WA, Novikovs L, Henderson ES (1969) Leukocyte preservation. I. Phagocytic stimulation of the hexose monophosphate shunt as a measure of cell viability. J Lab Clin Med 73:327–337PubMedGoogle Scholar
  22. Solberg CO (1972) Evaluation of neutrophil granulocyte function. Acta Path Microbiol Scand B 80:559–563Google Scholar
  23. Wilkinson PC (1974) Chemotaxis and inflammation. Churchill Livingstone, Edinburgh and LondonGoogle Scholar
  24. Wright DG, Kirkpatrick CH, Gallin JI (1977) Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest 59:941–950PubMedGoogle Scholar
  25. Zigmond SH, Hirsch JG (1973) Leukocyte locomotion and chemotaxis. New method for evaluation and demonstration of cell-derived chemotactic factors. J Exp Med 137:387–410CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • F. Patrone
    • 1
  • F. Dallegri
    • 1
  • E. Bonvini
    • 1
  • F. Minervini
    • 1
  • C. Sacchetti
    • 1
  1. 1.Second Medical Clinic, Department of Internal MedicineUniversity of Genova Medical SchoolGenovaItaly

Personalised recommendations